苏州丰倍生物科技股份有限公司首次公开发行股票主板上市公告书提示性公告

Listing Overview - Suzhou Fengbei Biotechnology Co., Ltd. will be listed on the Shanghai Stock Exchange on November 5, 2025, with a total share capital of 143.5 million shares, of which 35.9 million shares are newly issued [1][4]. Initial Public Offering (IPO) Details - The IPO price is set at 24.49 CNY per share, corresponding to a price-to-earnings (P/E) ratio of 21.28 times based on the 2024 earnings before non-recurring gains and losses [4]. - The total number of shares available for public trading after the IPO will be 31.05 million shares, accounting for 21.64% of the total share capital [3][4]. Market Comparisons - The average static P/E ratio for the waste resource comprehensive utilization industry is reported at 64.73 times as of October 22, 2025 [5]. - The diluted P/E ratio of the company at the IPO price is 30.47 times, which is lower than the industry average and comparable companies' average P/E ratios [6]. Trading Risks - The first five trading days will have no price fluctuation limits, which may lead to significant price volatility [2]. - The limited number of circulating shares may pose liquidity risks in the initial trading period [3]. Contact Information - The company is located at Jiangsu Yangtze River International Chemical Industrial Park, and the contact number is 0512-58329931 [8]. - The lead underwriter is Guotai Junan Securities Co., Ltd., located in Shanghai, with a contact number of 021-38032666 [9].